9786204209852 - in-silico approach for alpha-glycosidase and urease inhibitor search de redhu, neelam; khatkar, anurag (5 resultados)

- Tapa blanda
Librería: moluna, Greven, Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 58,12
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New.

- Tapa blanda
Librería: preigu, Osnabrück, Alemaniapreigu
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 61,05
Envío por EUR 70,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 5 disponibles
Taschenbuch. Condición: Neu. In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search | Neelam Redhu (u. a.) | Taschenbuch | Englisch | 2021 | LAP LAMBERT Academic Publishing | EAN 9786204209852 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de…| Anbieter: preigu.

- Tapa blanda
- Impresión bajo demanda
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 71,90
Envío por EUR 23,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from pr…eclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively. 168 pp. Englisch.

- Tapa blanda
- Impresión bajo demanda
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 71,90
Envío por EUR 60,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from precli…nical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 168 pp. Englisch.

- Tapa blanda
- Impresión bajo demanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 72,76
Envío por EUR 61,34Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclin…ical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively.